Construction of a bivalent DNA vaccine co-expressing S genes of transmissible gastroenteritis virus and porcine epidemic diarrhea virus delivered by attenuated Salmonella typhimurium

[1]  Chun-Ming Lin,et al.  Experimental infection of a US spike-insertion deletion porcine epidemic diarrhea virus in conventional nursing piglets and cross-protection to the original US PEDV infection , 2015, Veterinary Research.

[2]  H. Moon,et al.  Porcine epidemic diarrhea: a review of current epidemiology and available vaccines , 2015, Clinical and Experimental Vaccine Research.

[3]  R. Morrison,et al.  Previous infection of sows with a "mild" strain of porcine epidemic diarrhea virus confers protection against infection with a "severe" strain. , 2015, Veterinary microbiology.

[4]  H. Shin,et al.  Evaluation of antibody response of killed and live vaccines against porcine epidemic diarrhea virus in a field study , 2014, The Veterinary quarterly.

[5]  Leyi Wang,et al.  New Variant of Porcine Epidemic Diarrhea Virus, United States, 2014 , 2014, Emerging infectious diseases.

[6]  Hyoung‐Chin Kim,et al.  Expression of the S glycoprotein of transmissible gastroenteritis virus (TGEV) in transgenic potato and its immunogenicity in mice , 2013 .

[7]  Li Fang,et al.  Origin, Evolution, and Genotyping of Emergent Porcine Epidemic Diarrhea Virus Strains in the United States , 2013, mBio.

[8]  K. Schwartz,et al.  Emergence of Porcine epidemic diarrhea virus in the United States: clinical signs, lesions, and viral genomic sequences , 2013, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

[9]  F. Meng,et al.  Evaluation on the Efficacy and Immunogenicity of Recombinant DNA Plasmids Expressing Spike Genes from Porcine Transmissible Gastroenteritis Virus and Porcine Epidemic Diarrhea Virus , 2013, PloS one.

[10]  Q. Yan,et al.  Immunogeiiicity of recombinant attenuated salmonella choleraesuis C500 strain co-expressing M and N protein of porcine epidemic diarrhea virus (PEDV) , 2012 .

[11]  S. Xiao,et al.  Complete Genome Sequence of Porcine Epidemic Diarrhea Virus Strain AJ1102 Isolated from a Suckling Piglet with Acute Diarrhea in China , 2012, Journal of Virology.

[12]  Qigai He,et al.  New Variants of Porcine Epidemic Diarrhea Virus, China, 2011 , 2012, Emerging infectious diseases.

[13]  S. Eo,et al.  Oral co-administration of live attenuated Salmonella enterica serovar Typhimurium expressing chicken interferon-α and interleukin-18 enhances the alleviation of clinical signs caused by respiratory infection with avian influenza virus H9N2. , 2012, Veterinary microbiology.

[14]  F. Meng,et al.  Immune responses induced by DNA vaccines bearing Spike gene of PEDV combined with porcine IL-18 , 2012, Virus Research.

[15]  J. Cui,et al.  Vaccination of Mice with ORF5 Plasmid DNA of PRRSV; Enhanced Effects by Co-immunizing with Porcine IL-15 , 2012, Immunological investigations.

[16]  Elizabeth A. Warner,et al.  Construction and screening of attenuated ΔphoP/Q Salmonella typhimurium vectored plague vaccine candidates , 2012, Human vaccines & immunotherapeutics.

[17]  D. Song,et al.  Porcine epidemic diarrhoea virus: a comprehensive review of molecular epidemiology, diagnosis, and vaccines , 2012, Virus Genes.

[18]  F. Chen,et al.  Isolation and characterization of a variant porcine epidemic diarrhea virus in China , 2012, Virology Journal.

[19]  Liu Di-qiu,et al.  High-level mucosal and systemic immune responses induced by oral administration with Lactobacillus-expressed porcine epidemic diarrhea virus (PEDV) S1 region combined with Lactobacillus-expressed N protein , 2011, Applied Microbiology and Biotechnology.

[20]  Tae-Geum Kim,et al.  Expression of a Cholera Toxin B Subunit-Neutralizing Epitope of the Porcine Epidemic Diarrhea Virus Fusion Gene in Transgenic Lettuce (Lactuca sativa L.) , 2011, Molecular biotechnology.

[21]  F. Meng,et al.  Bacterial expression of antigenic sites A and D in the spike protein of transmissible gastroenteritis virus and evaluation of their inhibitory effects on viral infection , 2011, Virus Genes.

[22]  Z. Pan,et al.  Oral and Nasal DNA Vaccines Delivered by Attenuated Salmonella enterica Serovar Typhimurium Induce a Protective Immune Response against Infectious Bronchitis in Chickens , 2011, Clinical and Vaccine Immunology.

[23]  Liu Di-qiu,et al.  Construction and characterization of Lactobacillus pentosus expressing the D antigenic site of the spike protein of Transmissible gastroenteritis virus. , 2011, Canadian journal of microbiology.

[24]  L. Enjuanes,et al.  Transmissible gastroenteritis virus (TGEV)-based vectors with engineered murine tropism express the rotavirus VP7 protein and immunize mice against rotavirus , 2010, Virology.

[25]  L. Qi,et al.  Non-Beijing Strains of Mycobacterium tuberculosis in China , 2010, Journal of Clinical Microbiology.

[26]  Chul-Joong Kim,et al.  Immunogenicity and protective efficacy of orally or intranasally administered recombinant Lactobacillus casei expressing ETEC K99. , 2010, Vaccine.

[27]  Zhifei Zhang,et al.  Oral vaccination with Ts87 DNA vaccine delivered by attenuated Salmonella typhimurium elicits a protective immune response against Trichinella spiralis larval challenge. , 2010, Vaccine.

[28]  Richard Barnett.  Diabetes , 1904, The Lancet.

[29]  Yi-jing Li,et al.  Oral immunization of mice with recombinant Lactococcus lactis expressing porcine transmissible gastroenteritis virus spike glycoprotein , 2009, Virus Genes.

[30]  Ying Tang,et al.  Intragastric administration of attenuated Salmonella typhimurium harbouring transmissible gastroenteritis virus (TGEV) DNA vaccine induced specific antibody production , 2009, Vaccine.

[31]  Huanchun Chen,et al.  Subcutaneous Vaccination with Attenuated Salmonella enterica Serovar Choleraesuis C500 Expressing Recombinant Filamentous Hemagglutinin and Pertactin Antigens Protects Mice against Fatal Infections with both S. enterica Serovar Choleraesuis and Bordetella bronchiseptica , 2008, Infection and Immunity.

[32]  K. Karaca,et al.  Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep. , 2007, Vaccine.

[33]  Y. Jang,et al.  Oral efficacy of Vero cell attenuated porcine epidemic diarrhea virus DR13 strain , 2006, Research in Veterinary Science.

[34]  I. Sola,et al.  Recombinant dimeric small immunoproteins neutralize transmissible gastroenteritis virus infectivity efficiently in vitro and confer passive immunity in vivo. , 2007, The Journal of general virology.

[35]  I. Sola,et al.  An antibody derivative expressed from viral vectors passively immunizes pigs against transmissible gastroenteritis virus infection when supplied orally in crude plant extracts , 2006, Plant biotechnology journal.

[36]  Tae-Geum Kim,et al.  Cloning and sequence analysis of the Korean strain of spike gene of porcine epidemic diarrhea virus and expression of its neutralizing epitope in plants. , 2005, Protein expression and purification.

[37]  Ze Chen,et al.  Induction of Th1 type response by DNA vaccinations with N, M, and E genes against SARS-CoV in mice , 2005, Biochemical and Biophysical Research Communications.

[38]  J. Kwang,et al.  Intragastric administration of Lactobacillus casei expressing transmissible gastroentritis coronavirus spike glycoprotein induced specific antibody production , 2004, Vaccine.

[39]  P. Jiang,et al.  Humoral immune response induced by oral administration of S. typhimurium containing a DNA vaccine against porcine reproductive and respiratory syndrome virus. , 2004, Veterinary immunology and immunopathology.

[40]  W. Goebel,et al.  Bacteria as DNA vaccine carriers for genetic immunization. , 2004, International journal of medical microbiology : IJMM.

[41]  S. Streatfield,et al.  A corn-based delivery system for animal vaccines: an oral transmissible gastroenteritis virus vaccine boosts lactogenic immunity in swine , 2004, Vaccine.

[42]  Y. Jang,et al.  Induction of antigen-specific systemic and mucosal immune responses by feeding animals transgenic plants expressing the antigen. , 2003, Vaccine.

[43]  D. Schifferli,et al.  Construction, Characterization, and Immunogenicity of an Attenuated Salmonella enterica Serovar Typhimurium pgtE Vaccine Expressing Fimbriae with Integrated Viral Epitopes from the spiC Promoter , 2003, Infection and Immunity.

[44]  G. Tian,et al.  Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes , 2003, Avian pathology : journal of the W.V.P.A.

[45]  Y. Jang,et al.  Identification of the epitope region capable of inducing neutralizing antibodies against the porcine epidemic diarrhea virus. , 2002, Molecules and cells.

[46]  J. Kim,et al.  Modulation of antigen-specific cellular immune responses to DNA vaccination in rhesus macaques through the use of IL-2, IFN-gamma, or IL-4 gene adjuvants. , 2001, Vaccine.

[47]  E. Nagy,et al.  Construction and characterization of recombinant porcine adenovirus serotype 5 expressing the transmissible gastroenteritis virus spike gene. , 2001, The Journal of general virology.

[48]  J. Kim,et al.  Prevalence of porcine epidemic diarrhoea virus and transmissible gastroenteritis virus infection in Korean pigs , 2000, Veterinary Record.

[49]  B. Stocker.  Aromatic-dependent salmonella as anti-bacterial vaccines and as presenters of heterologous antigens or of DNA encoding them. , 2000, Journal of biotechnology.

[50]  Papp,et al.  Ileal and jejunal Peyer’s patches play distinct roles in mucosal immunity of sheep , 1999, Immunology.

[51]  A. Chalian,et al.  Cytokine molecular adjuvants modulate immune responses induced by DNA vaccine constructs for HIV-1 and SIV. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[52]  L. Saif,et al.  Active and passive immune responses to transmissible gastroenteritis virus (TGEV) in swine inoculated with recombinant baculovirus-expressed TGEV spike glycoprotein vaccines. , 1997, American journal of veterinary research.

[53]  G. Korbutt,et al.  Cotransplantation of Allogeneic Islets With Allogeneic Testicular Cell Aggregates Allows Long-Term Graft Survival Without Systemic Immunosuppression , 1997, Diabetes.

[54]  M. Bullido,et al.  Cooperation between transmissible gastroenteritis coronavirus (TGEV) structural proteins in the in vitro induction of virus-specific antibodies , 1996, Virus Research.

[55]  R. Walker,et al.  New strategies for using mucosal vaccination to achieve more effective immunization. , 1994, Vaccine.

[56]  H. Laude,et al.  Processing and antigenicity of entire and anchor-free spike glycoprotein S of coronavirus TGEV expressed by recombinant baculovirus , 1991, Virology.

[57]  P. Leder,et al.  Humoral immune functions in IL-4 transgenic mice. , 1991, Journal of immunology.

[58]  K. Mcintosh,et al.  Coronaviruses: a comparative review. , 1974 .

[59]  V. Georgiev.  Virology , 1955, Nature.